Stay updated with breaking news from Nasdaq Bcli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group lowered shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a report on Thursday, September […]
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a report issued on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group downgraded shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, September […]
StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note released on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group cut Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research note on Thursday, September 28th. Check […]
StockNews.com started coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group lowered shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a report on […]
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 3,770,000 shares, an increase of 5.6% from the October 31st total of 3,570,000 shares. Based on an average daily volume of 2,320,000 […]